Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NPPHY | MKSI |
|---|---|---|
| Price | $3.86 | $280.50 |
| Change today | ▼ 4.22% | ▲ 0.48% |
| Market cap | $18.97B | $18.97B |
| Return, 3 months | +14.7% | -19.7% |
| Return, year to date | +11.2% | +76.0% |
| Return, 1 year | +11.2% | +101.9% |
| P/E (TTM) | 19.3 | 44.7 |
| P/B | 1.4 | 6.3 |
| P/E percentile vs own 5y | – | 73rd |
| Dividend yield | 1.24% | 0.34% |
| Revenue growth (YoY, latest qtr) | – | +28.3% |
| Net profit growth (YoY) | – | +182.3% |
| Gross margin | – | 47.0% |
| Operating margin | – | 16.7% |
| Net margin | – | 10.1% |
| Return on equity | – | 15.8% |
| Analyst target vs. price | – | +44.3% |
| Analyst buy share | – | 92% |
| RSI (14) | 54 | 59 |
| 30-day volatility | 125.2% | 50.8% |
| Max drawdown, 1 year | -32.6% | -47.9% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
